(Q43834965)

27 November 2017

title

Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score (English)

1 reference

27 November 2017

author

Jean-francois Bergmann

6

1 reference

27 November 2017

J Dumurgier

2

0 references

author name string

Y Kahouadji

1

1 reference

27 November 2017

P Sellier

3

1 reference

27 November 2017

P Lapalus

4

1 reference

27 November 2017

V Delcey

5

1 reference

27 November 2017

J Hugon

7

1 reference

27 November 2017

C Paquet

8

1 reference

27 November 2017

language of work or name

1 reference

4 October 2012

1 reference

27 November 2017

1 reference

27 November 2017

volume

14

1 reference

27 November 2017

issue

5

1 reference

27 November 2017

page(s)

311-315

1 reference

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Changing incidence of central nervous system diseases in the EuroSIDA cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Does highly active antiretroviral therapy improve neurocognitive function? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Clock drawing in Alzheimer's disease. A novel measure of dementia severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

[Validation of a brief screening scale evaluating praxic abilities for use in memory clinics. Evaluation in 419 controls, 127 mild cognitive impairment and 320 demented patients].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01052.X

10.1111/J.1468-1293.2012.01052.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference